Ionis therapeutics stock
Web13 jul. 2024 · For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three... Web13 apr. 2024 · Fate Therapeutics Inc. (NASDAQ:FATE) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -0.53% to the previous day’s close …
Ionis therapeutics stock
Did you know?
Web29 jun. 2024 · ABOUT AKCEA THERAPEUTICS, INC. Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), is a biopharmaceutical company focused on developing and... Web27 mrt. 2024 · Ionis Pharmaceuticals Inc’s stock is NA in 2024, NA in the previous five trading days and up 4.88% in the past year. Currently, Ionis Pharmaceuticals Inc does not have a price-earnings ratio. Ionis Pharmaceuticals Inc’s trailing 12-month revenue is $587.4 million with a -45.9% net profit margin.
Web23 jun. 2024 · We believe that the stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is … Web28 mrt. 2024 · For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises.
Web9 apr. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS) has a market capitalization of $5.33 billion and generates $587 million in revenue each year. The company earns $ … Web31 aug. 2024 · Promptly following the completion of the tender offer, Ionis will acquire all remaining shares of Akcea common stock at the same price of $18.15 per share in cash …
WebIonis Pharmaceuticals Inc Follow Share $37.23 After Hours: $37.23 (0.00%) 0.00 Closed: Apr 11, 7:29:48 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Crispr …
Web31 mrt. 2024 · ionis pharmaceuticals, inc. (NASDAQ:IONS) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share IONIS PHARMACEUTICALS, … binghamton campus visitWeb16 dec. 2024 · Ionis ( NASDAQ: IONS) is currently trading at $29.73 while it has an intrinsic value of $49.27. The short-term catalyst that will move this stock in 2024 is increased market share for Spinraza.... czech clip art imagesWebIonis Pharmaceuticals, Inc. beschäftigt sich mit der Entdeckung und Entwicklung von Ribonukleinsäure (RNA)-gezielten Therapeutika. Das Unternehmen konzentriert sich in erster Linie auf die Bereiche Herz-Kreislauf und Neurologie. czech city of a hundred spiresWeb13 apr. 2024 · United Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $282.88, representing a 24.6% upside. In a report issued on April 10, UBS also maintained a Buy... czech clip art black \u0026 whiteWebWith Ionis Pharmaceuticals stock trading at $35.48 per share, the total value of Ionis Pharmaceuticals stock (market capitalization) is $5.07B. Ionis Pharmaceuticals stock … binghamton cardiology associatesWeb12 apr. 2024 · Buy candidate since 2024-04-05 Gain 1.86% PDF. The Ionis Pharmaceuticals stock price gained 1.86% on the last trading day (Thursday, 6th Apr … czech city named city of a hundred spiresWeb28 feb. 2024 · Ionis reports fourth quarter and full year 2024 financial results. Feb 21, 2024. Ionis announces new donidalorsen data and presentations at the 2024 American … binghamton car rental